DAA741 |
Cerebral blood flow and glucose utilization are reduced |
Physiological |
brain |
Human |
— |
— |
|
DAA738 |
Cerebral spinal fluid amount increases |
Physiological |
brain |
Human |
— |
— |
|
DAA2297 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
93.8% Increase Gene Expression Level |
|
DAA2303 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
parietal lobe |
Human |
CCR1 |
53.9% Increase Gene Expression Level |
|
DAA2302 |
Chemokine (C-C motif) receptor 1 increases with age |
Molecular |
parietal lobe |
Human |
CCR1 |
129.2% Increase Gene Expression Level |
|
DAA2296 |
Chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
182.5% Increase Gene Expression Level |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
temporal lobe |
Human |
CX3CL1 |
46.7% Decrease Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2305 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
parietal lobe |
Human |
CX3CL1 |
56.2% Decrease Gene Expression Level |
|
DAA2304 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
parietal lobe |
Human |
CX3CL1 |
61.0% Decrease Gene Expression Level |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
frontal lobe |
Human |
CXCL16 |
44.1% Increase Gene Expression Level |
|
DAA2306 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
parietal lobe |
Human |
CXCL16 |
78.9% Increase Gene Expression Level |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
hippocampus |
Human |
CXCL16 |
100.6% Increase Gene Expression Level |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
Molecular |
hippocampus |
Human |
CXCL5 |
64.9% Increase Gene Expression Level |
|
DAA43 |
chimerin (chimaerin) 1 |
Molecular |
brain |
Human |
CHN1 |
6.0% Decrease Gene Expression Level |
|
DAA39 |
cholecystokinin |
Molecular |
brain |
Human |
CCK |
6.0% Decrease Gene Expression Level |
|
DAA40 |
cholecystokinin B receptor |
Molecular |
brain |
Human |
CCKBR |
11.0% Decrease Gene Expression Level |
|
DAA27 |
chromosome 1 open reading frame 95 |
Molecular |
brain |
Human |
C1orf95 |
5.0% Decrease Gene Expression Level |
|
DAA28 |
chromosome 5 open reading frame 13 |
Molecular |
brain |
Human |
C5orf13 |
8.0% Decrease Gene Expression Level |
|
DAA124 |
chromosome 5 open reading frame 30 |
Molecular |
brain |
Human |
C5orf30 |
19.0% Decrease Gene Expression Level |
|
DAA29 |
chromosome 6 open reading frame 106 |
Molecular |
brain |
Human |
C6orf106 |
12.0% Decrease Gene Expression Level |
|
DAA2201 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
25.5% Increase Gene Expression Level |
|